Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery (TheRAPy): a Multiple Period Vanguard Cluster Crossover Trial

NCT06230198 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT06230198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06230198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery (TheRAPy): a Multiple Period Vanguard Cluster Crossover Trial
Lead sponsor
Population Health Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2024
Completion date
November 30, 2026
Enrollment
4,500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

red blood cell transfusion